The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire

NCT00901004 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1550

Last updated 2010-12-07

No results posted yet for this study

Summary

The purpose of this study is to define the endoscopic findings of minimal change that is significant to clinical significant reflux esophagitis. Through this, the investigators want to estimate the applicability of minimal change findings of reflux esophagitis to the clinic.

Conditions

  • Gastroesophageal Reflux Disease

Sponsors & Collaborators

Principal Investigators

  • Joonwoo Bahn · Astrazenca Korea, Medical Department

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Completion
2009-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00901004 on ClinicalTrials.gov